Valsartan Amlodipine Tablets (Ⅰ) Obtain Registration Approval
Release time:
2023-06-12
News from our newspaper Recently, Jianfeng Pharmaceutical received the Valsartan Amlodipine Tablets (I) "Drug Registration Certificate") approved and issued by the State Drug Administration.
Valsartan and Amlodipine Tablets (I)(specifications: each tablet contains 80mg of valsartan and 5mg of amlodipine) were developed by Novartis Pharmaceuticals (Novartis). They were approved by EMA for listing in the European Union in January 2007, FDA for listing in the United States in June 2007 and approved for listing in China in September 2009. Valsartan amlodipine tablets (I) are used for the treatment of essential hypertension and for patients whose blood pressure cannot be fully controlled by monotherapy. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2022) ", classified as Class B; and has been included in the" National Essential Drug List (2018 Edition) ".
Peak Pharmaceutical submitted its registration application to the Drug Evaluation Center of the State Drug Administration on December 16, 2021 and was accepted, and was approved for listing in China on May 19, 2023. The acquisition of Valsartan Amlodipine Tablets (I) "Drug Registration Certificate" this time indicates that Jianfeng Pharmaceutical is qualified to produce and sell the drug, which will further enrich the product range of Jianfeng Pharmaceutical and help to enhance the competitiveness of the company's pharmaceutical business. (Xu Chunliu)
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08